Search

Nausea and vomiting are experienced by 40–70% of advanced cancer patients, with 35% having those symptoms in the last six weeks of life. Aprepitant is a selective NK-1 receptor antagonist that blocks the emetogenic action of... Read more

Management of procedural pain related to cancer and its treatment is poorly addressed in the literature. This audit was conducted across three radiotherapy treatment centres in Australia. One hundred and thirty patients were... Read more

Individuals with metastatic disease are consented to CAncer tiSsue Collection After DEath (CASCADE) when they reach the end-of-life stage and understand that there are no further curative options available. Tissue donated to... Read more

Sponsor  Associate Professor Odette Spruyt  Principal investigators  International lead: Dr Andrew Davies  Royal Marsden Hospital, Surrey, UK.  Peter Mac Principal... Read more

Sponsor  Peter MacCallum Cancer Centre  Principal investigator/s  Associate Professor Odette Spruyt  Palliative care consultant  Contact  Associate Profeesor Odette Spruyt... Read more

Sponsor  Peter MacCallum Cancer Centre  Principal investigator  Dr Sonia Fullerton  Deputy Chief Medical Officer  Contact details  Dr Sonia Fullerton - Principal... Read more